The pharmacokinetic/pharmacodynamic profile of tepoxalin and RWJ-20142 suggest that the drug is a selective COX-1 inhibitor in horses, with no significant anti-inflammatory activity.
By inhibiting dipeptidyl peptidase-4 (DPP-4), teneligliptin provides a therapeutic option for type 2 diabetes mellitus (T2DM) that is widely used in Asia. A generic product could lessen treatment costs, provided that its systemic availability is equivalent to that of the branded formulation. Such comparative informatio...
Zhao-Feng Guan, Ming-Qi Chen, Bi-Ying Wei et al.· BMC Pharmacology and Toxicol...· 0 citations
The available PK data on sitagliptin from published studies in healthy and diseased subjects are summarized and may be useful for developing physiologically based PK models and may provide additional information to support clinicians in optimizing sitagliptin dosing in patient populations.
Tahira Saleem, M. Rasool, Hamid Saeed et al.· Therapeutic Drug Monitoring· 0 citations
Ursodeoxycholic acid (UDCA) is a secondary bile acid used in humans for the treatment of some cholestatic diseases. Interest in its potential use in equine patients with liver conditions has increased. Pharmacokinetic parameters in adult horses have recently been reported; however, they are not available for foals. The...
T. Burdette, B. Delvescovo, E. W. Bellin et al.· Journal of Veterinary Pharma...· 0 citations
Meloxicam (MLX) is a preferential cyclooxygenase-2 inhibitor widely used in avian medicine as an anti-inflammatory agent. Despite marked interspecific variability in avian drug disposition, no pharmacokinetic data are available for MLX in the white stork (
Ciconia ciconia
). This study aimed to characterise a...
Y. Gunes, Ebuderda Gunay, N. Yılmaz et al.· BMC Veterinary Research· 0 citations
Balcinrenone (AZD9977) is a novel selective non‐steroidal mineralocorticoid receptor antagonist with a distinct mode of action being developed as a fixed‐dose combination with the sodium–glucose cotransporter‐2 inhibitor dapagliflozin for the treatment of heart failure with impaired kidney function, and chronic kidney...
A. Eriksson, D. Karsanji, Amy H. Shi et al.· Journal of clinical pharmaco...· 0 citations
INTRODUCTION
Fluconazole is a triazole antifungal agent commonly used to treat both systemic and superficial fungal infections. This comprehensive review aims to collate all published pharmacokinetic (PK) data on fluconazole in healthy and diseased subjects.
METHODS
A systematic search of Google Scholar, PubMed, and...
Tahira Saleem, Khadija Ameen, M. Rasool et al.· Expert Review of Anti-Infect...· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.